OLIX

OLIX is a biotech company in London, United Kingdom, founded in 2010. It has raised $213.0M across 1 round, most recently a $213.0M Series A in February 2026.

Driving drug development through next-generation oligonucleotide technology

Headquarters
London
Employees
51–200
Founded
2010
Business Model
B2B
Total Funding
$213.0M
Last Round
$213.0M Series AFeb 2026
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 4 investors for this company. The full record is or through the API.

About

OliX Pharmaceuticals is a clinical-stage biopharmaceutical company developing RNA interference (RNAi) therapeutics using its proprietary cp-asiRNA and asiRNA platform technologies. The company is the first Asian organization to advance a self-developed RNAi technology into clinical trials, targeting dermal, ophthalmic, pulmonary, and hepatic diseases. Listed on KOSDAQ (226950), OliX is headquartered in Suwon, South Korea.

Summary

It lists 51–200 employees. It has raised $213.0M in total across 1 round, most recently a $213.0M Series A round in Feb 2026. Investors include octopus investments, LocalGlobe and Entrepreneur First.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series ASeries AFeb 2026
$213.0M

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

OLIX on Indexed.vc
<a href="https://indexed.vc/companies/olix"><img src="https://indexed.vc/api/badge/company/olix" alt="OLIX on Indexed.vc" width="260" height="76" /></a>